Investment adviser · CRD 286040
BAY CITY CAPITAL GF XINDE INVESTMENT MANAGEMENT CO
Exempt reporting adviser (ERA)
Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.
SAN RAFAEL, CA, United States · Form ADV filed Oct 11, 2024
Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →
Private funds & service providers
1 Private fundThe count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.
BAY CITY CAPITAL GF XINDE INTERNATIONAL LIFE SCIENCES USD FUND, L.P.Venture Capital Fund · Last reported Oct 11, 2024$17.7MGross asset value
Form D fundraising filings
Bay City Capital GF Xinde International Life Sciences USD Fund, L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
FRANK, RIMERMAN & CO. LLP
PCAOB 1596
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221 · LEI 8NAV47T0Y26Q87Y0QP81
Fund details & source
- Fund ID
- 805-1055263489
- Reported beneficial owners
- 15
- Minimum commitment
- $0
- Form D file number
- 021-273681
Form ADV 1906433 · Oct 11, 2024 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
Services & filing details
Most recent filing: Oct 11, 2024. View historical filings
Reported services
Not reported in these imported fields
Compensation
Not reported in these imported fields
Principal office
1000 4TH STREET, SUITE 500SAN RAFAEL, CA, 94901, United States
CRD 286040
Filing source
Form ADV 1906433 · Oct 11, 2024 · Items 1 & 5
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.